INDV
INDIVIOR PHARMA (INDV)
NASDAQ
$38.98-$0.98 (-2.46%)
Price as of Jun 23, 2026 7:55 PM EDT
  • $4.5B
    Market Cap
  • 174.70%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
Income Statement
Total Operating Revenue
1.2B
+4.29%
1.2B
+8.69%
1.1B
N/A
Cost of Revenue
246.0M
+6.49%
231.0M
+24.19%
186.0M
N/A
Gross Profit
994.0M
+3.87%
957.0M
+5.51%
907.0M
N/A
Sales and Marketing Expense
634.0M
+2.59%
618.0M
-23.80%
811.0M
N/A
Research and Development Expense
-97.0M
-9.35%
-107.0M
+0.94%
-106.0M
N/A
Depreciation and Amortization Expense
10.0M
-65.52%
29.0M
+52.63%
19.0M
N/A
Total Operating Expenses
246.0M
-73.41%
925.0M
+14.06%
811.0M
N/A
Operating Profit
262.0M
+718.75%
32.0M
+900.00%
-4.0M
N/A
Interest Income
22.0M
-4.35%
23.0M
N/A
N/A
N/A
Interest Expense
-38.0M
+18.75%
-32.0M
N/A
N/A
N/A
Interest Income and Expense and Net
-16.0M
+77.78%
-9.0M
N/A
0
N/A
Total Nonoperating Income and Expense
N/A
N/A
N/A
N/A
6.0M
N/A
Income before Taxes
239.0M
+1,607.14%
14.0M
+600.00%
2.0M
N/A
Income Taxes
29.0M
+163.64%
11.0M
+1,200.00%
-1.0M
N/A
Extraordinary Items
19.0M
+137.50%
8.0M
N/A
N/A
N/A
Net Income
210.0M
+10,400.00%
2.0M
0.00%
2.0M
N/A
Net Income from Continuing Operations Applicable to Common
239.0M
+1,607.14%
14.0M
+600.00%
2.0M
N/A
Basic EPS and Net Income
1.68
+8,300.00%
0.02
N/A
N/A
N/A
Diluted EPS and Net Income
1.64
+8,100.00%
0.02
+100.00%
0.01
N/A
Basic Weighted Average Shares
125.0M
-5.30%
132.0M
-3.86%
137.3M
N/A
Diluted Weighted Average Shares
128.0M
-3.76%
133.0M
-3.14%
137.3M
N/A
Balance Sheet
Cash and Cash Equivalents
195.0M
-38.87%
319.0M
+0.95%
316.0M
N/A
Short-Term Investments
0
-100.00%
1.0M
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
195.0M
-39.06%
320.0M
+1.27%
316.0M
N/A
Total Current Assets
652.0M
-22.29%
839.0M
-33.57%
1.3B
N/A
Accumulated Depreciation
107.0M
+18.89%
90.0M
N/A
N/A
N/A
Property and Plant and Equipment and Net
144.0M
+44.00%
100.0M
+19.05%
84.0M
N/A
Total Long-Term Assets
27.0M
-6.90%
29.0M
-95.80%
691.0M
N/A
Total Assets
1.2B
-8.95%
1.3B
-32.50%
2.0B
N/A
Income Taxes Payable
2.0M
-71.43%
7.0M
N/A
N/A
N/A
Total Short-Term Debt
29.0M
+61.11%
18.0M
+500.00%
3.0M
N/A
Total Current Liabilities
914.0M
-2.66%
939.0M
-28.05%
1.3B
N/A
Total Long-Term Debt
290.0M
-7.94%
315.0M
N/A
N/A
N/A
Total Long-Term Liabilities
21.0M
+16.67%
18.0M
-97.23%
649.0M
N/A
Total Liabilities
1.3B
-22.06%
1.7B
-14.64%
2.0B
N/A
Retained Earnings
-243.0M
-46.48%
-454.0M
-136.50%
1.2B
N/A
Total Stockholders Equity
-98.0M
-71.84%
-348.0M
N/A
0
N/A
Total Shares Outstanding
125.0M
0.00%
125.0M
-9.26%
137.8M
N/A
Cash Flow
Cash from Operating Activities
-27.0M
-175.00%
36.0M
+111.43%
-315.0M
N/A
Capital Expenditures
66.0M
+127.59%
29.0M
N/A
N/A
N/A
Cash from Investing Activities
-66.0M
-195.65%
69.0M
+170.41%
-98.0M
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
-30.0M
-70.59%
-102.0M
+121.74%
-46.0M
N/A
Financials Ratio
Gross Margin
80.15%
-0.51%
80.56%
N/A
N/A
N/A
Operating Margin
21.15%
+685.05%
2.69%
N/A
N/A
N/A
Return on Assets
16.67%
+13,538.87%
0.12%
N/A
N/A
N/A
Return on Equity
-94.17%
+8,093.01%
-1.15%
N/A
N/A
N/A
Revenue Growth
4.29%
-50.61%
8.69%
N/A
N/A
N/A
Current Ratio
0.71
-20.17%
0.89
N/A
N/A
N/A
Cash Ratio
0.21
-37.21%
0.34
N/A
N/A
N/A
Debt-to-Equity Ratio
-3.26
+240.17%
-0.96
N/A
N/A
N/A
Debt-to-Assets Ratio
0.27
+5.19%
0.25
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow